BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24127568)

  • 21. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
    Rojo AI; Medina-Campos ON; Rada P; Zúñiga-Toalá A; López-Gazcón A; Espada S; Pedraza-Chaverri J; Cuadrado A
    Free Radic Biol Med; 2012 Jan; 52(2):473-87. PubMed ID: 22142471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
    Zhang DD; Lo SC; Cross JV; Templeton DJ; Hannink M
    Mol Cell Biol; 2004 Dec; 24(24):10941-53. PubMed ID: 15572695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
    Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
    J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.
    Zhang Z; Cui W; Li G; Yuan S; Xu D; Hoi MP; Lin Z; Dou J; Han Y; Lee SM
    J Agric Food Chem; 2012 Aug; 60(33):8171-82. PubMed ID: 22838648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.
    Niture SK; Jaiswal AK
    J Biol Chem; 2012 Mar; 287(13):9873-9886. PubMed ID: 22275372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
    Shibata T; Ohta T; Tong KI; Kokubu A; Odogawa R; Tsuta K; Asamura H; Yamamoto M; Hirohashi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13568-73. PubMed ID: 18757741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrachlorobenzoquinone activates Nrf2 signaling by Keap1 cross-linking and ubiquitin translocation but not Keap1-Cullin3 complex dissociation.
    Su C; Zhang P; Song X; Shi Q; Fu J; Xia X; Bai H; Hu L; Xu D; Song E; Song Y
    Chem Res Toxicol; 2015 Apr; 28(4):765-74. PubMed ID: 25742418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
    Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
    Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
    Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keap1 degradation by autophagy for the maintenance of redox homeostasis.
    Taguchi K; Fujikawa N; Komatsu M; Ishii T; Unno M; Akaike T; Motohashi H; Yamamoto M
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13561-6. PubMed ID: 22872865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
    Sekhar KR; Rachakonda G; Freeman ML
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):21-6. PubMed ID: 19560482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS; Tseng YT; Hsu YY; Lo YC
    Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of human Keap1 S53 and S293 residues in modulating the binding of Keap1 to Nrf2.
    Wei S; Pei Y; Wang Y; Guan H; Huang Y; Xing T; Johnson RW; Wang D
    Biochimie; 2019 Mar; 158():73-81. PubMed ID: 30576774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.
    Keum YS
    Ann N Y Acad Sci; 2011 Jul; 1229():184-9. PubMed ID: 21793854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2.
    Sekhar KR; Yan XX; Freeman ML
    Oncogene; 2002 Oct; 21(44):6829-34. PubMed ID: 12360409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
    Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
    Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.